Intrafamilial spread of the same clarithromycin-resistant Helicobacter pylori infection confirmed by molecular analysis

Journal of Clinical Microbiology

Volumn 42, Issue 8, 2004, Pages 3901-3903

  Taneike, Ikue ^a   Suzuki, Keibun ^b   Nakagawa, Saori ^a   Yamamoto, Tatsuo ^a  

^a NIIGATA UNIVERSITY GRADUATE SCHOOL OF MEDICAL AND DENTAL SCIENCES   (Japan)

^b Shigaraki National Hospital   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CLARITHROMYCIN;

ADULT; ARTICLE; BACTERIAL INFECTION; BACTERIUM ISOLATION; CASE REPORT; DNA DETERMINATION; DRUG RESISTANCE; EPIGASTRIC PAIN; FAMILIAL DISEASE; FEMALE; GASTRITIS; HELICOBACTER PYLORI; HIGH RISK PATIENT; HUMAN; PEPTIC ULCER; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RIBOTYPING; STRAIN DIFFERENCE;

ADULT; AMOXICILLIN; BREATH TESTS; CHILD; CLARITHROMYCIN; DISEASE TRANSMISSION, HORIZONTAL; DRUG THERAPY, COMBINATION; FEMALE; GASTRITIS; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; UREA;

BACTERIA (MICROORGANISMS); HELICOBACTER; HELICOBACTER PYLORI;

EID: 3843063504     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.42.8.3901-3903.2004     Document Type: Article

References (21)

1. Cabrita, J., M. Oleastro, R. Matos, A. Manhente, J. Cabral, R. Barros, A. L. Lopes, P. Ramalho, B. C. Neves, and A. S. Guerreiro. 2000. Features and trends in Helicobacter pylori antibiotic resistance in Lisbon area, Portugal (1990-1999). J. Antimicrob. Chemother. 46:1029-1031.
2. Cayla, R., F. Zerbib, P. Talbi, F. Megraud, and H. Lamouliatte. 1995. Pre and post-treatment clarithromycin resistance of Helicobacter pylori strains. Gut 37:A55.
3. Clayton, C. L., H. Kleanthous, P. J. Coates, D. D. Morgan, and S. Tabaqehali. 1992. Sensitive detection of Helicobacter pylori by using polymerase chain reaction. J. Clin. Microbiol. 30:192-200.
4. Debets-Ossenkopp, Y. J., M. Sparrius, J. G. Kusters, J. J. Kolkman, and C. M. Vandenbroucke-Grauls. 1996. Mechanism of clarithromycin resistance in clinical isolates of Helicobacter pylori. FEMS Microbiol. Lett. 142:37-42.
5. Dzierzanowska-Fangrat, K., E. Rozynek, P. Jowiak, D. Celinska-Cedro, K. Madalinski, and D. Dzierzanowska. 2001. Primary resistance to clarithromycin in clinical strains of Helicobacter pylori isolated from children in Poland. Int. J. Antimicrob. Agents 18:387-390.
6. Gerhard, M., N. Lehn, N. Neumayer, T. Boren, R. Rad, W. Schepp, S. Miehlke, M. Classen, and C. Prinz. 1999. Clinical relevance of the Helicobacter pylori gene for blood-group antigen-binding adhesin. Proc. Natl. Acad. Sci. USA 96:12778-12783.
7. Goodwin, C. S. 1997. Helicobacter pylori gastritis, peptic ulcer, and gastric cancer: clinical and molecular aspects. Clin. Infect. Dis. 25:1017-1019.
8. Graham, D. Y. 2000. Therapy of Helicobacter pylori: current status and issues. Gastroenterology 118:S2-S8.
9. IARC Working Group. 1994. Schistosomes, liver flukes and Helicobacter pylori. IARC Monogr. Eval. Carcinog. Risks Hum. 61:177-241.
10. Kalach, N., M. Bergeret, P. H. Benhamou, C. Dupont, and J. Raymond. 2001. High levels of resistance to metronidazole and clarithromycin in Helicobacter pylori strains in children. J. Clin. Microbiol. 39:394-397.
11. López-Brea, M., M. J. Martinez, D. Domingo, and T. Alarcón. 2001. A 9 year study of clarithromycin and metronidazole resistance in Helicobacter pylori from Spanish children. 1. Antimicrob. Chemother. 48:295-297.
12. Megraud, F., N. Lehn, T. Lind, E. Bayerdorffer, C. O'Morain, R. Spiller, P. Unge, S. V. van Zanten, M. Wrangstadh, and C. F. Burman. 1999. Antimicrobial susceptibility testing of Helicobacter pylori in a large multicenter trial: the MACH 2 study. Antimicrob. Agents Chemother. 43:2747-2752.
13. National Committee for Clinical Laboratory Standards. 2001. MIC interpretive standards (μg/ml) for Helicobacter pylori, p. 107. In Methods for dilution of antimicrobial susceptibility tests for bacteria that grow aerobically, 5th ed. Approved standard. M7-A5, vol. 21, no. 1 (Performance standards for antimicrobial susceptibility testing; 11th informational supplement. M100-S11). National Committee for Clinical Laboratory Standards, Wayne, Pa.
14. Taneike, I., S. Goshi, Y. Tamura, N. Wakisaka-Saito, N. Matsumori, A. Yanase, T. Shimizu, Y. Yamashiro, S. Toyoda, and T. Yamamoto. 2002. Emergence of clarithromycin-resistant Helicobacter pylori (CRHP) with a high prevalence in children compared with their parents. Helicobacter 7:297-305.
15. Taneike, I., Y. Tamura, T. Shimizu, Y. Yamashiro, and T. Yamamoto. 2001. Helicobacter pylori intrafamilial infections: change in source of infection of a child from father to mother after eradication therapy. Clin. Diagn. Lab. Immunol. 8:731-739.
16. Tompkins, D. S., J. Perkin, and C. Smith. 1997. Failed treatment of Helicobacter pylori infection associated with resistance to clarithromycin. Helicobacter 2:185-187.
17. Torres, J., M. Camorlinga-Ponce, G. Pérez-Pérez, A. Madrazo-De la Garza, M. Dehesa, G. González-Valencia, and O. Muñoz. 2001. Increasing multidrug resistance in Helicobacter pylori strains isolated from children and adults in Mexico. J. Clin. Microbiol. 39:2677-2680.
18. Vakil, N., B. Hahn, and D. McSorley. 1998. Clarithromycin-resistant Helicobacter pylori in patients with duodenal ulcer in the United States. Am. J. Gastroenterol. 93:1432-1435.
19. Yamaoka, Y., E. Orito, M. Mizokami, O. Gutierrez, N. Saitou, T. Kodama, M. S. Osato, J. G. Kim, F. C. Ramirez, V. Mahachai, and D. Y. Graham. 2002. Helicobacter pylori in North and South America before Columbus. FEBS Lett. 517:180-184.
20. Yamaoka, Y., T. Kodama, M. Kita, J. Imanishi, K. Kashima, and D. Y. Graham. 1999. Relation between clinical presentation, Helicobacter pylori density, interleukin 1β and 8 production, and cagA status. Gut 45:804-811.
21. Yamaoka, Y., T. Kodama, O. Gutierrez, J. G. Kim, K., Kashima, and D. Y. Graham. 1999. Relationship between Helicobacter pylori iceA, cagA, and vacA status and clinical outcome: studies in four different countries. J. Clin. Microbiol. 37:2274-2279.